Neurology

THE AMERICAN OPTOMETRIC ASSOCIATION LAUNCHES ‘THE EYE’ TO EDUCATE AMERICANS ON PROTECTING THE MOST ADVANCED TECH – THEIR EYES

This year, AOA's Eye Deserve More campaign encourages consumers to prioritize their eye health as much as their technology ST.…

4 months ago

NeuroXT and BIDMC Join Forcesto Revolutionize Alzheimer’s Treatment with AI

New Partnership Aims to Tailor Alzheimer's Treatments Using Cutting-Edge AI Technology BOSTON, Aug. 22, 2024 /PRNewswire/ -- In a groundbreaking move…

4 months ago

Ultrasound Market to be Worth $18.07 billion by 2031 – Exclusive Report by Meticulous Research®

REDDING, Calif., Aug. 21, 2024 /PRNewswire/ -- According to a new market research report, 'Ultrasound Market Size, Share, Forecast, & Trends Analysis…

4 months ago

Oragenics Inc. Completes Spray Dry Drug Manufacturing and Intranasal Device Filling in Anticipation of Phase IIa Clinical Trial in Concussed Patients

• Falls and car accidents lead incidence of concussions in emergency departments • Spray-dried drug formulation allows for easy delivery to patients…

4 months ago

Rose Hill Announces Addition of Two Senior Advisors to Advisory Team

Burton J. Tabaac MD, FAHA and Rotem Petranker, M.A. Set to Bolster Rose Hill’s Psychedelic Research EffortsWORCESTER, Mass., Aug. 21,…

4 months ago

Real-world Evidence Solutions Market to be Worth $6.37 Billion by 2031–Exclusive Report by Meticulous Research®

REDDING, Calif., Aug. 19, 2024 /PRNewswire/ -- According to a new market research report titled, "Real-world Evidence Solutions Market Size, Share, Forecast,…

4 months ago

Ardent Health Reports Second Quarter 2024 Results

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health Partners, Inc. (NYSE: ARDT) (“Ardent Health” or the “Company”), a leading provider of healthcare in growing…

4 months ago

Ardent Health Reports Second Quarter 2024 Results

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health Partners, Inc. (NYSE: ARDT) (“Ardent Health” or the “Company”), a leading provider of healthcare in growing…

4 months ago

Oragenics Inc. Shows Concussion Drug, ONP-002, Designed for Acute Field-Delivery Stable Across a Wide Temperature Range

• ONP-002 stability eliminates need for cumbersome cold storage• No FDA-approved pharmaceutical treatment available for concussion SARASOTA, Fla., Aug. 14,…

4 months ago